Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT

Cobo Marc received 9,038 Bridgebio Oncology Therapeutics, Inc. shares as an award (Form 4)

Traded Sep 10, 2026 · Filed Sep 14, 2026

On Sep 10, 2026, Cobo Marc (Principal Accounting Officer) received 9,038 Bridgebio Oncology Therapeutics, Inc. shares as an award, leaving 14,141 shares. Filed Sep 14, 2026 (Form 4).

Awarded
9,038 shares
Holding after
14,141 shares
Trading plan
No
Role
Principal Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 10, 2026Common StockAward9,03814,344Direct
Sep 10, 2026Common StockShares withheld for tax203US$5.5214,141Direct

Source

View original at SEC

Related